Eye drug Eylea has mysterious rise in side effect reports
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Minneapolis
DOCTORS say they're seeing an unexplained increase in a rare, frightening side effect in patients getting Regeneron Pharmaceuticals' top-selling product, the blockbuster eye drug Eylea.
After the drug is injected into the eye, a small number of people have a sharp decline in sight, experience pain, and can panic. While the effect is treatable and doesn't lead to long-term vision loss, a professional society of eye physicians has warned members to look out for the condition.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
20 photos that show how dramatically Singapore has changed in two decades
Singapore’s key exports up 15.3% in March from electronics surge, exceeding forecasts